At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Left Atrial Appendage Closuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
In Brief
A clinical study evaluating Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation. Completed, enrolled 20 participants across 1 site.
Detailed Summary
A prospective, single center, open-label, single arm, study to evaluate the safety and technical performance of the CLAAS system for closure of the left atrial appendage.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-valvular Atrial Fibrillation
CountriesCzechia
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedDec 2019
Primary CompletionOct 2022
Study CompletionDec 2022
TodayJul 2026
First PostedDec 10, 2019
Enrollment StartOct 19, 2019
Primary CompletionOct 30, 2022
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.6 years ago
Interventions
Left Atrial Appendage Closuredevice
Closure of the left atrial appendage (LAAC) is performed percutaneously. Implantation of the LAAC device will be performed according to device specific instructions for use based on both TEE guidance, ICE and angiography, femoral access and inter-atrial septum crossing